have prepared a polymer micelle system loaded with RSL3, a GPX4 inhibitor, for triggering ferroptosis and reverse multidrug resistance.[58] More significant works are expected in the future to harness lipid metabolism and tumor ferroptosis effectively for further elevating the cancer‐therapeutic outcome. Here, GPX4 is linked to cancer.